Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-06-27Clinical Trial Update: Sequence Towards Remission in Depression [Phase 4]
This clinical trial update concerns a Phase 4 study titled 'Sequence Towards Remission in Depression,' with the current status not disclosed…
-
FDA approval · 2012-06-26FDA Approved: CITALOPRAM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's supplemental application for citalopram under an ANDA, confirming approval of a generic cital…
-
FDA approval · 2012-06-26FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical’s supplemental application for venlafaxine hydrochloride, a generic product. The approval relates to the sta…
-
CLINICAL_TRIALS trial_result · 2012-06-25Clinical Trial Update: Building Recovery By Improving Goals, Habits, and Thoughts [NA]
A completed clinical trial sponsored by RAND addressing Depression and Substance Use; results posted in 2012.
-
CLINICAL_TRIALS research · 2012-06-25Clinical Trial Update: Description of Treatment Management of Patients With Major Depressive Disorder and Inadequate Response
This trial update describes treatment-management approaches for patients with major depressive disorder who have had an inadequate response …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-22Clinical Trial Update: Randomised Controlled Trial of Electroconvulsive Therapy (ECT) in Relapse Prevention of Depression [Phase 4]
A Phase 4 randomized trial evaluating electroconvulsive therapy for relapse prevention in major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-20Clinical Trial Update: Bupropion For Reducing High-Risk Behaviors in Depressed Men Who Have Sex With Men (MSM) [Phase 1]
Phase 1 clinical trial update evaluating whether bupropion can reduce high-risk behaviors in depressed men who have sex with men (MSM). The …
-
FDA approval · 2012-06-19FDA Approved: OLANZAPINE AND FLUOXETINE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved the original application for a fixed-dose combination of olanzapine and fluoxetine (olanzapine/fluoxetine) by Teva Pharmaceutic…
-
CLINICAL_TRIALS trial_result · 2012-06-19Clinical Trial Update: Quetiapine Extended Release Depression Symptoms [Phase 3]
A Phase 3 trial evaluating quetiapine extended-release for schizophrenia and depressive symptoms has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: Deep Brain Stimulation for Treatment-Refractory Major Depression [Phase 1]
Phase 1 clinical trial evaluating deep brain stimulation for treatment-refractory major depression, conducted at University Hospital Bonn; t…
-
FDA approval · 2012-06-12FDA Approved: ESCITALOPRAM OXALATE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original ANDA for escitalopram oxalate, a generic version of the antidepressant, for treating major dep…
-
CLINICAL_TRIALS trial_result · 2012-06-11Clinical Trial Update: Disseminating Evidence-based Mood Disorder Chronic Care Models [NA]
The University of Michigan-sponsored trial has completed and focused on disseminating evidence-based chronic care models for mood disorders,…
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: A Local Register Study For Major Depression Of Paroxetine Controlled Release [Phase 3]
A Phase 3 local register study evaluating paroxetine controlled release for major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: Feasibility of Depression Care Management by E-mail [NA]
A completed Kaiser Permanente trial evaluating the feasibility of managing depression care via email, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-05-31Clinical Trial Update: A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease [Phase 1]
Phase 1 clinical trial investigating the relationship between inflammatory markers, depressive symptoms, and heart disease, which has been t…
-
FDA approval · 2012-05-29FDA Approved: CITALOPRAM HYDROBROMIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic citalopram hydrobromide product manufactured by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2012-05-25Clinical Trial Update: Evaluation of the Potential Effects of SSR149415 on the Hypothalamic-pituitary-adrenal Axis in Outpatients With Major Depressive Disorder [Phase 2]
Phase 2 clinical trial evaluating the potential effects of SSR149415 on the hypothalamic-pituitary-adrenal axis in outpatients with major de…
-
CLINICAL_TRIALS trial_result · 2012-05-25Clinical Trial Update: An Intervention Study to Increase Physical Activity and Maternal Well-being During Pregnancy [EARLY_Phase 1]
An early-phase trial evaluating an intervention to increase physical activity and maternal well-being during pregnancy has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-23Clinical Trial Update: Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients [Phase 3]
Phase 3 clinical trial comparing quetiapine XR as monotherapy versus augmentation with lithium in treatment-resistant depression. Results we…
-
FDA approval · 2012-05-21FDA Approved: CITALOPRAM — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
FDA approved a supplemental application for citalopram submitted by Chartwell Governmental & Specialty RX, LLC.
-
CLINICAL_TRIALS trial_result · 2012-05-21Clinical Trial Update: Phase IV Trial With Pramipexole to Evaluate Safety and Efficacy in Patients With RLS Associated With Mood Disturbances [Phase 4]
This Phase IV trial update reports the completion of a study evaluating the safety and efficacy of pramipexole for restless legs syndrome as…
-
FDA approval · 2012-05-21FDA Approved: CITALOPRAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for citalopram by Hikma Pharmaceuticals USA Inc., authorizing the continued marketing of a generic c…
-
CLINICAL_TRIALS research · 2012-05-15Clinical Trial Update: Reminiscence Therapy on Depression, Self Esteem, Life Satisfaction, and Loneliness of the Elderly [Phase 2]
Phase 2 study evaluating reminiscence therapy and its effects on depression, self-esteem, life satisfaction, and loneliness in elderly indiv…
-
CLINICAL_TRIALS research · 2012-05-15Clinical Trial Update: The Effects of Escitalopram on Cytokines [NA]
This clinical trial investigates whether escitalopram affects cytokine levels in individuals with depression; the current status of the stud…
-
CLINICAL_TRIALS trial_result · 2012-05-11Clinical Trial Update: Acceleration and Relapse Prevention With Triiodothyronine (T3) as an Adjunct to Electroconvulsive Therapy (ECT)
A completed trial assessed whether adding tri-iodothyronine (T3) to electroconvulsive therapy accelerates antidepressant response. The study…